Advertisement

Urine mutagenicity, chromosomal abnormalities and sister chromatid exchanges in lymphocytes of nurses handling cytostatic drugs

  • I. Stucker
  • A. Hirsch
  • T. Doloy
  • I. Bastie-Sigeac
  • D. Hemon
Article

Summary

The effects of handling antineoplastic drugs were examined in 17 nurses working in a pneumology department in a hospital in the Paris area. Twenty-five others in the same department who were not handling such drugs acted as controls. Exposure to antineoplastic drugs was evaluated by questionnaire and by assessment of urine mutagenicity. The cytogenetic repercussions of exposure were assessed by examining sister chromatid exchanges and chromosomal abnormalities in circulating lymphocytes. The urine of the exposed nurses was significantly more mutagenic than that of the controls. No cytogenetic abnormalities were revealed in the exposed subjects since both these and the control nurses exhibited similar frequencies of chromosomal abnormalities and similar average numbers of sister chromatid exchanges in circulating lymphocytes. However, in smokers, the urine was significantly more mutagenic compared to that of nonsmokers, chromosomal abnormalities were twice as frequent, and the number of sister chromatid exchanges was significantly larger. Comparison of these results with the findings of other authors suggests that the moderate exposure to antineoplastic drugs prevailing in this pneumology department (i.e., an average of about 11 infusions per week) does not cause detectable cytogenetic abnormalities even though it significantly increases urine mutagenicity.

Key words

Antineoplastic drugs Chromosome damage Occupational exposure Urine mutagenicity assay Mutagens 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ames NB, McCann J, Yamasaki E (1975) Methods for detecting carcinogens and mutagens with the Salmonella/Mammalian-Microsome mutagenicity test. Mutat Res 31:347–364CrossRefPubMedGoogle Scholar
  2. Anderson RW, Puckett WH, Dana WJ, Nguyen TV, Theiss JC, Matney TS (1982) Risk of handling injectable antineoplastic agents. Am J Hosp Pharmacol 39:1881–1887Google Scholar
  3. Armitage P (1980) Statistical methods in medical research, 5th edn. Springer Blackwell Scientific Publications, OxfordGoogle Scholar
  4. Bos RP, Leenaars AO, Theuws JLG, Henderson PTh (1982) Mutagenicity of urine from nurses handling cytostatic drugs, influence of smoking. Int Arch Occup Environ Health 50:359–369PubMedGoogle Scholar
  5. Dolara P, Mazzoli S, Rosi D (1981) Exposure to carcinogenic chemicals and smoking increases urinary excretion of mutagens in humans. J Tox Environ Health 8:95–103Google Scholar
  6. Fagnani F, Thierry JP, Maccia C, Lefaure C, Benedittini M, Mizrahi A, Faure H (1985) Enquête nationale sur le radiodiagnostic. Aspects méthodologiques. J Radiologie 66:167–174Google Scholar
  7. Falck K, Gröhn P, Sorsa M, Vainio H, Heinonen E, Holsti LR (1979) Mutagenicity in urine of nurses handling cytostatic drugs. Lancet 9:1250–1251CrossRefGoogle Scholar
  8. Falck K (1982) Urinary mutagenicity caused by smoking. In: Mutagens in our environment. Alan R Liss, Inc, New York, pp 387–400Google Scholar
  9. Gibson JF, Baxter PJ, Edworth Whitty RB, Gompertz D (1983) Urinary mutagenicity assays: a problem arising from the presence of histidine associated growth factors in XAD-2 prepared urine concentrates, with particular relevance to assays carried out using the bacterial fluctuation test. Carcinogene 4:1471–1476Google Scholar
  10. Husgafvel-Pursiainen K, Mäki-Paakkanen J, Norppa H, Sorsa M (1980) Smoking and sister chromatid exchange. Hereditas 92:247–250PubMedGoogle Scholar
  11. Husum B, Wulf HC, Niebuhr E (1982) Normal sister chromatid exchanges in oral contraceptive users. Mutat Res 103:161–164CrossRefPubMedGoogle Scholar
  12. IARC (1981) IARC monographs on the evaluation of the carcinogenic risk of the chemicals to humans. Some antineoplastic and immunosuppressive agents, vol 26Google Scholar
  13. Knuutila S, Mäki-Paakkanen J, Kahkonen M, Hokkanen E (1978) An increased frequency of chromosomal changes in cultured blood lymphocytes of 12 subjects vaccinated against smallpox. Hum Genet 41:89–96CrossRefPubMedGoogle Scholar
  14. Kolmodin-Hedman B, Hartvig P, Sorsa M, Falck K (1983) Occupational handling of cytostatic drugs. Arch Toxicol 54:25–33PubMedGoogle Scholar
  15. Kucerova M, Polivkova Z, Matousek V (1980) Chromosomal aberrations and SCE in lymphocytes of children revaccinated against smallpox. Mutat Res 71:263–267PubMedGoogle Scholar
  16. Kurvink K, Bloomfield CD, Cervenka J (1978) Sister chromatid exchange in patients with viral disease. Exp Cell Res 113:450PubMedGoogle Scholar
  17. Lambert B, Ringborg V, Harper E, Lindblad A (1978a) Sister chromatid exchange in lymphocyte culture of patients. Cancer Treat Rep 62:1413–1419PubMedGoogle Scholar
  18. Lambert B, Lindblad A, Nordenskjöld M, Werelius B (1978b) Increased frequency of sister chromatid exchanges in cigarette smokers. Hereditas 88:147–149PubMedGoogle Scholar
  19. Lambert B, Ringbord V, Lindblad A (1979a) Prolonged increase of sister chromatid exchanges in lymphocytes of melanomia patients after CCNU treatment. Mutat Res 59:295–300PubMedGoogle Scholar
  20. Lambert B, Ehrnst A, Hansson K, Lindblad A, Morad M, Werelius B (1979b) Sister chromatid exchanges in peripheral lymphocytes of subjects vaccinated against measles. Hum Genet 50:291–296PubMedGoogle Scholar
  21. Lambert B, Bredberg A, McKenzie W, Sten M (1982) Sister chromatid exchange in human populations: the effect of smoking, drug treatment, and occupational exposure. Cytogenet Cell Genet 33:62–67PubMedGoogle Scholar
  22. Livingston GK, Fineman RM (1983) Correlation of human lymphocytes with smoking history. Mutat Res 119:59–64CrossRefPubMedGoogle Scholar
  23. Mule SJ, Bastos ML, Jukofsky D, Saffer E (1971) Routine identification of drugs of abuse in human urine — II. Development and application of the XAD-2 resin column method. J Chromatogr 63:289–301CrossRefPubMedGoogle Scholar
  24. Murthy Bala Krishna P (1979a) Frequency of sister chromatid exchanges in cigarette smokers. Hum Genet 52:343–345PubMedGoogle Scholar
  25. Murthy Bala Krishna P, Prema K (1979b) Sister chromatid exchanges in oral contraceptive users. Mutat Res 68:149–152PubMedGoogle Scholar
  26. Musilova J, Michalova K, Urban J (1979) Sister chromatid exchange and chromosomal breakage in patients treated with cytostatics. Mutat Res 67:289–294PubMedGoogle Scholar
  27. Nikula E, Kiviniitty K, Leisti J, Taskinen P (1984) Chromosome aberrations in lymphocytes of nurses handling cytostatic agents. Scand J Work Environ Health 10:71–74PubMedGoogle Scholar
  28. Norppa H, Sorsa M, Vainio H, Gröhn P, Heinonen E, Holsti L, Nordman E (1980) Increased sister chromatid exchange frequencies in lymphocytes of nurses handling cytostatic drugs. Scand J Work Environ Health 6:299–301PubMedGoogle Scholar
  29. Obe G, Vogt HJ, Madle S, Fahning A, Heller WD (1982) Double blind study on the effect of cigarette smoking on the chromosomes of human peripheral blood lymphocytes in vivo. Mutat Res 92:309–319PubMedGoogle Scholar
  30. Siebert S, Adamson RH (1975) Toxicity of antineoplastic agents in man: chromosomal aberrations, antifertility effects, congenital malformations and carcinogenic potential. Adv Cancer Res 22:57–155PubMedGoogle Scholar
  31. Stainio N, Gallelli JF, Adamson RH, Thorgeirsson SS (1981) Lack of mutagenic activity in urine from hospital pharmacists admixing antitumour drugs. Lancet 14:615–616CrossRefGoogle Scholar
  32. Stiller A, Obe G, Boll I, Pribilla W (1983) No elevation of the frequencies of chromosomal alterations as a consequence of handling cytostatic drugs. Analyses with peripheral blood and urine of hospital personnel. Mutat Res 121:253–259CrossRefPubMedGoogle Scholar
  33. Van Doorn R, Bos RP, Leigdeckers CM (1979) Thioether concentration and mutagenicity of urine from cigarette smokers. Int Arch Occup Environ Health 43:159–166PubMedGoogle Scholar
  34. Venitt S, Crofton-Sleigh C, Hunt C, Speechley V, Briggs K (1984) Monitoring exposure of nursing and pharmacy personnel to cytotoxic drugs: urinary mutation assays and urinary platinum as marker of absorption. Lancet 14:74–76CrossRefGoogle Scholar
  35. Vijayalaxmi, Evans HJ (1982) In vivo and in vitro effects of cigarette smoke on chromosomal damage and sister chromatid exchange in human peripheral blood lymphocytes. Mutat Res 92:321–322PubMedGoogle Scholar
  36. Waksvik H, Klepp O, Brogger A (1981) Chromosome analyses of nurses handling cytostatic agents. Cancer Treat Rep 63:607–611Google Scholar
  37. Yamasaki E, Ames BN (1977) Concentration of mutagens from urine by adsorption with the nonpolar resin XAD-2: cigarette smokers have mutagenic urines. Proc Natl Acad Sci [USA] 74, 8:3555–3559Google Scholar

Copyright information

© Springer-Verlag 1986

Authors and Affiliations

  • I. Stucker
    • 1
  • A. Hirsch
    • 2
  • T. Doloy
    • 3
  • I. Bastie-Sigeac
    • 4
    • 5
  • D. Hemon
    • 1
  1. 1.INSERM, U.170Villejuif Cedex
  2. 2.Service de PneumologieHôpital St. LouisParis Cedex 10
  3. 3.Commissariat à l'Energie AtomiqueCentre d'Études de Fontenay aux RosesFrance
  4. 4.INSERM, U.139, C.H.U. Henri MondorCréteilFrance
  5. 5.Laboratoire de Toxicologie GénétiqueInstitut PasteurParisFrance

Personalised recommendations